New drug combo tested for tough childhood cancers
NCT ID NCT01946529
Summary
This study is testing a new combination of drugs for young patients (up to age 25) with high-risk Ewing sarcoma and desmoplastic small round cell tumors. Patients are divided into two groups: those with lower-risk tumors receive standard treatment, while those with higher-risk tumors receive an experimental drug combination. The goal is to see if the new treatment helps control these difficult cancers better than current options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOPLASTIC SMALL ROUND CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.